Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025 2025-10-16 10:30
Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline 2025-10-15 23:05
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia 2025-10-15 20:00
Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth 2025-10-15 08:00
Benchling Reveals the Next Chapter of R&D at Benchtalk 2025 2025-10-14 21:14
India's No:1 Ranked Institute IIT Madras partners with Hyundai Motor India to launch 'Hyundai Hope for Cancer' to revolutionize Paediatric Cancer Care 2025-10-14 20:30
Kyoto University Engineering Ph.D. Team Achieves Technology Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge" 2025-10-14 20:30
India's No:1 Ranked Institute IIT Madras partners with Hyundai Motor India to launch 'Hyundai Hope for Cancer' to revolutionize Paediatric Cancer Care 2025-10-14 20:30
Clover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults 2025-10-14 18:18
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration 2025-10-14 18:00
Kyoto University Engineering Ph.D. Team Realizes Achievement Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge" 2025-10-14 17:22
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-TKI, a Novel Multi-tyrosine Kinase Inhibitor with Potent Immune Activation, at the 2025 ESMO Annual Meeting 2025-10-14 14:26
HKEX to Introduce Hang Seng Biotech Index Futures 2025-10-14 12:43
NABR Comment on IUCN Determination 2025-10-14 06:55
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data 2025-10-13 21:00
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood 2025-10-13 18:00
ReviR Therapeutics Receives Orphan Drug Designation from FDA for RTX-117 to Treat Charcot-Marie-Tooth Disease 2025-10-13 18:00
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development 2025-10-13 08:10
Roche Collaborates with OASES to Drive Primary Healthcare Transformation and Innovation, Strengthening Hong Kong's Position as a Global Healthcare Hub 2025-10-10 21:11
Vietnam's Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025 2025-10-10 15:43